A new modality of anti-cancer drug: Ferritin-drug conjugates.

被引：0
|
作者：
Lee, Jeewon
Lee, Bo Ram
Seol, Yong Hwan
Hwang, Hyun Ju
机构：
[1] Cellemedy, Seongnam, South Korea
[2] Korea Univ, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14590
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ψ-Bufarenogin, a lead compound of anti-cancer drug
    Ding, Jin
    Wang, Hongyang
    [J]. CELL CYCLE, 2015, 14 (17) : 2719 - 2720
  • [42] CYTEMBENA - ANTI-CANCER DRUG WITH AN UNIQUE STRUCTURE
    VONHOFF, DD
    ROZENCWEIG, M
    MUGGIA, FM
    [J]. BIOMEDICINE, 1977, 26 (06): : 388 - 392
  • [43] Extracellular vesicles and anti-cancer drug resistance
    Mc Namee, Niamh
    O'Driscoll, Lorraine
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (02): : 123 - 136
  • [44] Atropisomerism transforming anti-cancer drug discovery
    Patel, Simran
    Sandha, Khushi
    Waingankar, Anushka
    Jain, Prachi
    Abhyankar, Arundhati
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 101 (01) : 138 - 157
  • [45] Arsenic sulfide as a potential anti-cancer drug
    Ding, Wenping
    Zhang, Lian
    Kim, Sungkyoung
    Tian, Wei
    Tong, Yingying
    Liu, Jianwen
    Ma, Yong
    Chen, Siyu
    [J]. MOLECULAR MEDICINE REPORTS, 2015, 11 (02) : 968 - 974
  • [46] Computational approaches to anti-cancer drug design
    Taylor, SA
    Feldgus, S
    Shields, GC
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U505 - U506
  • [47] Signalling Pathways in Anti-cancer Drug Resistance
    Chen, Chen
    Chen, Jiezhong
    Zhao, Kong-Nan
    [J]. CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3007 - 3008
  • [48] Zeneca and Roche promote anti-cancer drug
    不详
    [J]. CHEMISTRY IN BRITAIN, 1998, 34 (10) : 11 - 11
  • [49] Pharmacokinetic evaluation of a novel anti-cancer drug
    Donnarumma, F.
    Greilberger, J.
    Matzi, V.
    Lindenmann, J.
    Maier, A.
    Leis, H. -J.
    Wintersteiger, R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 320 - 320
  • [50] Indian anti-cancer drug trials halted
    Sharma, DC
    [J]. LANCET, 1999, 353 (9154): : 735 - 735
12345